Search research articles
Contact Us
Filters
Showing results (11-20 of 124) with videos related to
Page
of 13
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 6, 2022
Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune-Mediated Inflammatory Diseases in the US
Jessica Leung, Tara C Anderson, Kathleen Dooling, et al.
The Journal of Rheumatology
|
October 16, 2020
Benefits of Methotrexate Use on Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients Initiating Biologic Disease-modifying Antirheumatic Drugs
Fenglong Xie, Lang Chen, Huifeng Yun, et al.
Annals of the Rheumatic Diseases
|
April 27, 2016
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
Jeffrey R Curtis, Fenglong Xie, Huifeng Yun, et al.
Arthritis Care & Research
|
February 7, 2018
Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data
Jeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Arthritis Care & Research
|
September 4, 2018
Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients
Fenglong Xie, Huifeng Yun, Emily B Levitan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2025
Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors?
Deanna Jannat-Khah, Jeffrey R Curtis, Fenglong Xie, et al.
Journal of Clinical Medicine Research
|
September 17, 2016
Budesonide Use and Hospitalization Rate in Crohn's Disease: Results From a Cohort at a Tertiary Care IBD Referral Center
Jordan Orr, Krishna V R Venkata, Steven Young, et al.
Gastroenterology Research
|
March 8, 2018
Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
Chaitanya Allamneni, Krishna Venkata, Huifeng Yun, et al.
Bone
|
November 7, 2023
The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare
Ye Liu, Tarun Arora, Jingyi Zhang, et al.
Arthritis Care & Research
|
April 28, 2025
Survival in Immune Checkpoint Inhibitor-Treated Patients With Rheumatoid Arthritis and Non-Small Cell Lung Cancer: An Observational Cohort Study
Deanna P Jannat-Khah, Fenglong Xie, Ashish Saxena, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 124) with videos related to
Sort By:
Page
of 13
Arthritis & Rheumatology (Hoboken, N.J.)
|
June 6, 2022
Recombinant Zoster Vaccine Uptake and Risk of Flares Among Older Adults With Immune-Mediated Inflammatory Diseases in the US
Jessica Leung, Tara C Anderson, Kathleen Dooling, et al.
The Journal of Rheumatology
|
October 16, 2020
Benefits of Methotrexate Use on Cardiovascular Disease Risk Among Rheumatoid Arthritis Patients Initiating Biologic Disease-modifying Antirheumatic Drugs
Fenglong Xie, Lang Chen, Huifeng Yun, et al.
Annals of the Rheumatic Diseases
|
April 27, 2016
Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
Jeffrey R Curtis, Fenglong Xie, Huifeng Yun, et al.
Arthritis Care & Research
|
February 7, 2018
Evaluation of a Methodologic Approach to Define an Inception Cohort of Rheumatoid Arthritis Patients Using Administrative Data
Jeffrey R Curtis, Fenglong Xie, Lang Chen, et al.
Arthritis Care & Research
|
September 4, 2018
Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients
Fenglong Xie, Huifeng Yun, Emily B Levitan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2025
Are Glucocorticoids Associated with Worse Survival among Rheumatoid Arthritis Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors?
Deanna Jannat-Khah, Jeffrey R Curtis, Fenglong Xie, et al.
Journal of Clinical Medicine Research
|
September 17, 2016
Budesonide Use and Hospitalization Rate in Crohn's Disease: Results From a Cohort at a Tertiary Care IBD Referral Center
Jordan Orr, Krishna V R Venkata, Steven Young, et al.
Gastroenterology Research
|
March 8, 2018
Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center
Chaitanya Allamneni, Krishna Venkata, Huifeng Yun, et al.
Bone
|
November 7, 2023
The interruption of romosozumab treatment during COVID lockdown among US post-menopausal women enrolled in Medicare
Ye Liu, Tarun Arora, Jingyi Zhang, et al.
Arthritis Care & Research
|
April 28, 2025
Survival in Immune Checkpoint Inhibitor-Treated Patients With Rheumatoid Arthritis and Non-Small Cell Lung Cancer: An Observational Cohort Study
Deanna P Jannat-Khah, Fenglong Xie, Ashish Saxena, et al.
Page
of 13